Ann: Change of FY23 Financial Results Announcement Date, page-2

I don't think shareholders are concerned about EBITDA, or whether there has been a drop or elimination of growth although Shine have to correct any previous statements made and this statement does that. However the reversal of EBITDA is the least of the issues here, it is more about cash in hand, and/or debt and cash conversion. EBITDA will return immediately to normal levels and growth in following years but the financial health of the company and ongoing future NPAT is another issue that only the accounts will tell. It does appear that SHJ will take some medicine now which is a positive.